\ BIP! Finder for COVID-19 - Impact-based ranking
Open dataset
Publication

BIP! Finder for COVID-19

Statistics
@BipFinder

This version of BIP! Finder aims to ease the exploration of COVID-19-related literature by enabling ranking articles based on various impact metrics.

Last Update: 18 - 01 - 2023 (628506 entries)

Provided impact measures:
Popularity: Citation-based measure reflecting the current impact.
Influence: Citation-based measure reflecting the total impact.
Reader Attention: The current number of Mendeley readers.
Social Media Attention: The number of recent tweets related to this article.
*More details on these impact measures can be found here.
Score interpretations:
Exceptional score (in top 0.01%).
Substantial score (in top 1%).
Average score (in bottom 99%).
Score not available.
Main data sources:
CORD-19 dataset(1) (list of papers)
LitCovid hub(2) (list of papers)
PMC & PubMed (citations)
Mendeley (number of readers)
COVID-19-TweetIDs(3) (tweets)

Use:  Impact  Relevance & Impact

Rank by:
Popularity Influence Reader Attention Social Media Attention

<< 45 46 47 48 49 >>

TitleVenueYearImpactSource
2301BBIBP-CorV: Steven-Johnson syndrome: case report  

N/A2022       CORD-19
2302Azd-1222: Inflammatory myositis and vasculitis: 3 case reports  

N/A2022       CORD-19
2303Tozinameran: Type 1 Kounis syndrome: case report  

N/A2022       CORD-19
2304Safety profile of mRNA vaccines during first 6 months of the US COVID-19 vaccination programme reviewed  

N/A2022       CORD-19
2305Bbibp-corv: Acute ischemic stroke: case report  

N/A2022       CORD-19
2306Elasomeran: Acute focal myocarditis: case report  

N/A2022       CORD-19
2307Ipragliflozin/tozinameran: Diabetic ketoacidosis: 2 case reports  

N/A2022       CORD-19
2308Ciprofloxacin/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report  

N/A2022       CORD-19
2309Elasomeran/insulin: Diabetic ketoacidosis, insulin resistance and lack of efficacy: case report  

N/A2022       CORD-19
2310Tozinameran/prednisone: Various toxicities: case report  

N/A2022       CORD-19
2311Elasomeran: Systemic vasculitis: case report  

N/A2022       CORD-19
2312Covid-19-vaccine: Severe isolated cardiomyopathy: case report  

N/A2022       CORD-19
2313AZD-1222: Multi-segmental Herpes zoster of dermatomes C3-4 on left side: case report  

N/A2022       CORD-19
2314Azd-1222: Fulminant myocarditis: case report  

N/A2022       CORD-19
2315Remdesivir: Extravasation: case report  

N/A2022       CORD-19
2316Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report  

N/A2022       CORD-19
2317Tozinameran: Myocarditis: case report  

N/A2022       CORD-19
2318AZD-1222: Superficial venous thrombosis: case report  

N/A2022       CORD-19
2319Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report  

N/A2022       CORD-19
2320Democracy and Sustainable Development  

The democratic discourse on climate change and sustainable development is becoming increasingly polarized. While some voters are pushing back against the movement to wean the world economy away from fossil fuels, others are questioning the huge costs that the transition to a green economy will impose and whether such attempts will have the required impact. This essay discusses the relationship between democracy and sustainable development by comparing the records of China and India in relation to the 2030 Agenda and the Sustainable Development Goals (SDGs). It argues that the politics of sustainable development has not received the attention it deserves. With a growing number of actors involved at various levels of society, the sustainable development narrative has often focused on a win–win narrative while glossing over areas where political agreement is more difficult to reach. While autocracies can achieve good results, democracy provides the best platform and guarantees for difficult negotiations and deliberations that are required for the achievement of sustainable development.

N/A2022       CORD-19
2321Estazolam/trazodone: Lack of efficacy in insomnia: case report  

N/A2022       CORD-19
2322Ad26.cov2-s: Thrombotic thrombocytopenia: case report  

N/A2022       CORD-19
2323Tozinameran: Flare-up of generalised pustular psoriasis and systemic capillary leak syndrome: case report  

N/A2022       CORD-19
2324Elasomeran: Lack of efficacy: case report  

N/A2022       CORD-19
2325Elasomeran: Leukocytoclastic vasculitic rash: case report  

N/A2022       CORD-19
2326Antibiotics/corticosteroids: Pneumonia following off-label use, oral pseudomembranous candidiasis, recurrent herpes labialis: case report  

N/A2022       CORD-19
2327AZD-1222: Flare of ulcerative colitis: case report  

N/A2022       CORD-19
2328Dexamethasone/remdesivir: Derangement of liver function tests, pneumocystis pneumonia and off-label use: case report  

N/A2022       CORD-19
2329Non-serious case reports  

N/A2022       CORD-19
2330Nivolumab: Cutaneous small-vessel thrombotic vasculopathy: case report  

N/A2022       CORD-19
2331Tozinameran: Relapse of adult-onset Still's disease: case report  

N/A2022       CORD-19
2332Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report  

N/A2022       CORD-19
2333Multiple drugs: Undetectable B-cells, lack of efficacy and off-label use: 3 case reports  

N/A2022       CORD-19
2334COVID-19 Vaccine Pfizer BioNTech: Vogt-Koyanagi-Harada disease exacerbation: case report  

N/A2022       CORD-19
2335Ad26.cov2-s: Inflammatory heart disease: case report  

N/A2022       CORD-19
2336Heparin: Heparin induced thrombocytopenia: case report  

N/A2022       CORD-19
2337Lorazepam: Lack of efficacy: case report  

N/A2022       CORD-19
2338AZD-1222: Bilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia: case report  

N/A2022       CORD-19
2339Elasomeran/tozinameran: Worsening of complex regional pain syndrome: 3 case reports  

N/A2022       CORD-19
2340Multiple drugs: Pneumocystis jirovecii pneumonia following off label use and hypersensitivity: case report  

N/A2022       CORD-19
2341Dexamethasone: Various toxicities and off-label use: case report  

N/A2022       CORD-19
2342Immune-globulin/methylprednisolone: Lack of efficacy: case report  

N/A2022       CORD-19
2343Baricitinib/methylprednisolone/prednisolone: Elevated HBV DNA following an off label use: case report  

N/A2022       CORD-19
2344COVID-19 vaccine Gamaleya National Research Center of Epidemiology and Microbiology: Myocarditis: case report  

N/A2022       CORD-19
2345Amiodarone: Interstitial lung disease: case report  

N/A2022       CORD-19
2346AZD-1222/immune-globulin/rituximab: Coronary antibody-mediated rejection, thrombosis and lack of efficacy: case report  

N/A2022       CORD-19
2347Aciclovir/dexamethasone/remdesivir: Lack of efficacy following off-label use: case report  

N/A2022       CORD-19
2348No increased risk for venous thromboembolism after COVID-19 vaccination  

N/A2022       CORD-19
2349Heparin: Lack of efficacy: case report  

N/A2022       CORD-19
2350Favipiravir: Lack of efficacy during the treatment with SARS-CoV-2 pneumonia: case report  

N/A2022       CORD-19

<< 45 46 47 48 49 >>

(1) COVID-19 Open Research Dataset (CORD-19). 2020. Version 2022-06-02. Retrieved from https://ai2-semanticscholar-cord-19.s3-us-west-2.amazonaws.com/historical_releases.html. Accessed 2022-06-05. doi:10.5281/zenodo.3715506
(2) Chen Q, Allot A, & Lu Z. (2020) Keep up with the latest coronavirus research, Nature 579:193 and Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Research. 2020. (version 2023-01-10)
(3) Currently tweets of June 23rd to June 29th 2022 have been considered.

Copyright ATHENA RC 2020, Developed by: Thanasis Vergoulis, Ilias Kanellos, Serafeim Chatzopoulos, and Danae Pla Karidi
This service is provided "as is", without any warranties of any kind.
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more
I accept